Cargando…

Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial

BACKGROUND: The benefits of adjuvant radiotherapy in rectal carcinoma are well known. However, there is still considerable uncertainty about the optimal radiation treatment. There is an ongoing debate about the choice between very short treatments immediately followed by surgical resection and prolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bisceglia, Giovanni, Mastrodonato, Nicola, Tardio, Berardino, Mazzoccoli, Gianluigi, Corsa, Pietro, Troiano, Michele, Parisi, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294367/ https://www.ncbi.nlm.nih.gov/pubmed/25373926

Ejemplares similares

Temozolomide and Radiotherapy versus Radiotherapy Alone in High Grade Gliomas: A Very Long Term Comparative Study and Literature Review
por: Parisi, Salvatore, et al.
Publicado: (2015)

Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta-Analysis
por: Yang, Jianguo, et al.
Publicado: (2022)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy
por: Koo, Kendrick, et al.
Publicado: (2021)

Persistent Haglund’s disease after conventional treatments: the innovative role of radiotherapy
por: di Chio, Francesca, et al.
Publicado: (2016)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
por: Delishaj, Durim, et al.
Publicado: (2021)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for malignant breast cancer
por: Fu, Wenyan, et al.
Publicado: (2018)

Editorial: Ano-rectal and gastro-esophageal cancer: diving into diagnostic and therapeutic imaging modalities for radiotherapy
por: Deantonio, Letizia, et al.
Publicado: (2023)

Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes
por: Chen, Nan, et al.
Publicado: (2019)

Effects of neoadjuvant chemotherapy with or without intensity‐modulated radiotherapy for patients with rectal cancer
por: He, Fang, et al.
Publicado: (2020)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
por: Zhang, Qibo, et al.
Publicado: (2021)

Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer
por: Tokuhara, Katsuji, et al.
Publicado: (2022)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
por: Wang, Jian, et al.
Publicado: (2021)

Correlations Between Intratumoral Microvessel Density and Histopathological Type or Neoadjuvant Radiotherapy for Rectal Carcinoma
por: DUMITRESCU, T., et al.
Publicado: (2015)

Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer
por: de Jong, Rianne, et al.
Publicado: (2021)

Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
por: Badesha, Jasleen K., et al.
Publicado: (2023)

[Corrigendum] Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer
por: Gassler, Nikolaus, et al.
Publicado: (2023)

Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?
por: Gao, Peng, et al.
Publicado: (2014)

Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment
por: Li, Jia-yi, et al.
Publicado: (2021)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
por: Spolverato, Gaya, et al.
Publicado: (2011)

Omission of neoadjuvant radiotherapy for clinical T2/N1 and T3N0/1 middle and low rectal cancers with safe circumferential resection margins
por: Lee, Kyung-Ha, et al.
Publicado: (2022)

Retinoid X Receptors Intersect the Molecular Clockwork in the Regulation of Liver Metabolism
por: De Cosmo, Salvatore, et al.
Publicado: (2017)

Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally‐advanced rectal cancer
por: Hardiman, Karin M., et al.
Publicado: (2019)

Neoadjuvant chemoradiotherapy or radiotherapy in patients aged 75 years or older with locally advanced rectal cancer
por: Liu, Xiaoliang, et al.
Publicado: (2020)

The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy
por: Alickikus, Zumre Arican, et al.
Publicado: (2019)

Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer
por: Doi, Hiroshi, et al.
Publicado: (2021)

Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer
por: Kang, Min Kyu
Publicado: (2023)

Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series
por: De Bari, Berardino, et al.
Publicado: (2019)

Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy
por: Foti, Pietro Valerio, et al.
Publicado: (2016)

Analysis of early postoperative complications in patients with resectable rectal cancer after neo-adjuvant chemo-radiotherapy
por: Grimaldi, Luciano, et al.
Publicado: (2013)

Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II–IV rectal cancer
por: Wu, Yinying, et al.
Publicado: (2017)

Association of markers of systemic and local inflammation with prognosis of patients with rectal cancer who received neoadjuvant radiotherapy
por: Zhang, Xueqing, et al.
Publicado: (2018)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age
por: Wu, Leilei, et al.
Publicado: (2017)

Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
por: Zhao, Mengjing, et al.
Publicado: (2021)

Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
por: Chin, Re-I, et al.
Publicado: (2022)

Molecular Composition of Serum Exosomes Could Discriminate Rectal Cancer Patients with Different Responses to Neoadjuvant Radiotherapy
por: Strybel, Urszula, et al.
Publicado: (2022)

Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer—Systematic Review
por: Smolskas, Edgaras, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fgeedad7dodpifqroen5tt6mck